2. Search Result
Search Result
Results for "

PF-03491390

" in MedChemExpress (MCE) Product Catalog:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-10396
    Emricasan
    35+ Cited Publications

    PF 03491390; IDN-6556

    		 Caspase Flavivirus Infection Neurological Disease Cancer
    Emricasan (PF 03491390) is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors .
    Emricasan
  • HY-10396R
    Emricasan (Standard)

    PF 03491390 (Standard); IDN-6556 (Standard)

    		 Caspase Flavivirus Infection Neurological Disease Cancer
    Emricasan (Standard) is the analytical standard of Emricasan. This product is intended for research and analytical applications. Emricasan (PF 03491390) is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors .
    Emricasan (Standard)
  • HY-10396A
    (2R,3S)-Emricasan

    (2R,3S)-PF 03491390; (2R,3S)-IDN-6556

    		 Caspase Flavivirus Infection Neurological Disease Cancer
    (2R,3S)-Emricasan ((2R,3S)-PF 03491390) is an isomer of Emricasan (HY-10396). Emricasan is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors .
    (2R,3S)-Emricasan